CXCR4 signaling potentiates homing of MM cells up SDF-1 gradients to bone marrow microenvironments that favor their survival and proliferation, and this has attracted attention as a possible therapeutic target in MM treatment [36]. The gene discussed is CXCR4; the disease is Miyoshi myopathy.